Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2026-01-01 @ 2:34 PM
Study NCT ID:
NCT00831766
Status:
COMPLETED
Last Update Posted:
2020-12-22
First Post:
2009-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2015-02-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-16
Completion Date Type:
ACTUAL
First Submit Date:
2009-01-28
First Submit QC Date:
None
Study First Post Date:
2009-01-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-02-25
Results First Submit QC Date:
None
Results First Post Date:
2016-03-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-01
Last Update Post Date:
2020-12-22
Last Update Post Date Type:
ACTUAL